World News Insights
1-3 Minute Gist

All Topics Article

Study: Hospitals Overpay for Devices

Wall Street Journal Original article ›

Keywords:


Failure to control overbilling by pharmaceutical companies, medical equipment and device makers in the health reform bill.

12/10/2009

Only $10 million annual increase to control fraud has been allocated in the bill. Its not likely to do much to control the overbilling and may be one more reason the health care reform bill will be a failure in controlling costs. Pricing of pharmaceutical products and healthcare services as the major unsolved problem in the U.S.

Grouped Articles

Health Care’s Road to Ruin

New York Times 12/21/2013

A Hole in Health-Care Reform

BusinessWeek 12/10/2009

How the Senate bill would contain the cost of health care : The New Yorker

New Yorker 01/04/2010

In Battle Over Health Law, Math Cuts Both Ways

New York Times 01/07/2011

House Approves Health Law Repeal

Wall Street Journal 01/20/2011

A grim diagnosis for our ailing U.S. health care system - The Washington Post

Washington Post 11/28/2011


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us